Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis

Usman Sabir; Hong‐mei Gu; Da‐Wei Zhang

doi:10.1002/ptr.7959

journal article Open Access Jul 17, 2023

Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis

Usman Sabir Hong‐mei Gu Da‐Wei Zhang

Phytotherapy Research Vol. 37 No. 11 pp. 4932-4962 · Wiley

View at Publisher Save 10.1002/ptr.7959

Abstract

AbstractExtracellular matrix (ECM) resolution by matrix metalloproteinases (MMPs) is a well‐documented mechanism. MMPs play a dual and complex role in modulating ECM degradation at different stages of liver fibrosis, depending on the timing and levels of their expression. Increased MMP‐1 combats disease progression by cleaving the fibrillar ECM. Activated hepatic stellate cells (HSCs) increase expression of MMP‐2, ‐9, and ‐13 in different chemicals‐induced animal models, which may alleviate or worsen disease progression based on animal models and the stage of liver fibrosis. In the early stage, elevated expression of certain MMPs may damage surrounding tissue and activate HSCs, promoting fibrosis progression. At the later stage, downregulation of MMPs can facilitate ECM accumulation and disease progression. A number of phytochemicals modulate MMP activity and ECM turnover, alleviating disease progression. However, the effects of phytochemicals on the expression of different MMPs are variable and may depend on the disease models and stage, and the dosage, timing and duration of phytochemicals used in each study. Here, we review the most recent advances in the role of MMPs in the effects of phytochemicals on liver fibrogenesis, which indicates that further studies are warranted to confirm and define the potential clinical efficacy of these phytochemicals.

Topics

No keywords indexed for this article. Browse by subject →

References

214

[1]

10.1007/s10620-005-9031-y

[2]

Hepatoprotective influence of quercetin and ellagic acid on thioacetamide-induced hepatotoxicity in rats

Nehal A. Afifi, Marwa A. Ibrahim, Mona K. Galal

Canadian Journal of Physiology and Pharmacology 10.1139/cjpp-2017-0651

[3]

10.1038/s41467-021-22167-3

[4]

10.3390/ijms231710148

[5]

10.1016/j.cbi.2014.03.009

[6]

10.3350/cmh.2017.0030

[7]

10.1089/ars.2013.5697

[8]

10.1016/s0167-4781(02)00477-3

[9]

10.1371/journal.pone.0112384

[10]

10.5152/tjg.2018.17330

[11]

10.1016/j.phrs.2017.12.020

[12]

10.1016/j.ajpath.2021.05.019

[13]

10.1038/ng1249

[14]

10.1177/1559325818789835

[15]

10.3390/ijms20102507

[16]

PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing

Stephan Barrientos, Olivera Stojadinovic, Michael S. Golinko et al.

Wound Repair and Regeneration 10.1111/j.1524-475x.2008.00410.x

[17]

The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities

Eleonora Binatti, Alessio Gerussi, Donatella Barisani et al.

International Journal of Molecular Sciences 10.3390/ijms23126649

[18]

10.1016/j.etap.2016.05.033

[19]

10.1074/jbc.m113.544494

[20]

Bodey B. "Immunocytochemical detection of MMP‐3 and‐10 expression in hepatocellular carcinomas" Anticancer Research (2000)

[21]

10.1016/j.cytogfr.2015.10.002

[22]

10.1002/path.5680

[23]

10.1089/ars.2015.6498

[24]

10.1002/jsfa.4723

[25]

10.1038/s42255-022-00529-5

[26]

10.3390/ijms23136894

[27]

10.3748/wjg.v20.i25.8082

[28]

10.1089/jmf.2015.0104

[29]

10.1016/j.stem.2018.05.027

[30]

Consolo M. "Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease" International Journal of Molecular Medicine (2009)

[31]

10.1002/hep.32239

[32]

10.1080/15376510601077003

[33]

10.3390/cells8111419

[34]

10.1089/jmf.2012.0175

[35]

10.1016/j.matbio.2015.01.004

[36]

10.1186/s13020-014-0027-4

[37]

10.1007/s00210-022-02264-w

[38]

10.1159/000328841

[39]

10.3389/fonc.2018.00357

[40]

10.3390/nu13113677

[41]

10.1210/er.2003-0027

[42]

10.1038/s41467-019-12930-y

[43]

10.3390/ijms20112700

[44]

Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

Scott L. Friedman, Massimo Pinzani

Hepatology 10.1002/hep.32285

[45]

10.1515/cclm-2014-0520

[46]

10.1111/liv.12337

[47]

10.3390/cells9051212

[48]

10.1111/jcmm.13304

[49]

10.3389/fphar.2018.00883

[50]

10.1042/bst20180363

Showing 50 of 214 references

Cited By

27

Effects of a High-Fat Diet and a Plant Extract Composition on Extracellular Matrix Remodeling in Rat Liver

O. P. Molodykh, L. B. Kim · 2026

Bulletin of Experimental Biology an...

Metrics

27

Citations

214

References

Details

Published: Jul 17, 2023
Vol/Issue: 37(11)
Pages: 4932-4962
License: View

Authors

U

Usman Sabir

Department of Pediatrics and Group on the Molecular and Cell Biology of Lipids, Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta Canada

H

Hong‐mei Gu

Department of Pediatrics and Group on the Molecular and Cell Biology of Lipids, Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta Canada

D

Da‐Wei Zhang

Department of Pediatrics and Group on the Molecular and Cell Biology of Lipids, Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta Canada

Cite This Article

Usman Sabir, Hong‐mei Gu, Da‐Wei Zhang (2023). Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis. Phytotherapy Research, 37(11), 4932-4962. https://doi.org/10.1002/ptr.7959

Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis

You May Also Like